JNJ vs PFE: Which Is the Better Dividend Stock?
A head-to-head dividend comparison of Johnson & Johnson and Pfizer Inc. — yield, payout safety, growth and total return. JNJ wins more categories overall.
| Metric | JNJ | PFE |
|---|---|---|
| Forward yield | 2.35% | 6.70% |
| Annual dividend | $5.36 | $1.72 |
| Payout ratio | 60% | 131% |
| Years of growth | 55 yr | 16 yr |
| 5-yr dividend growth | 5.2% | 3.6% |
| 5-yr total return | 41% | -34% |
| Dividend safety score | 89 (A) | 75 (B) |
| Frequency | quarterly | quarterly |
| Market cap | $549.3B | $146.4B |
| P/E ratio | 26.5 | 19.6 |
Higher yield
PFE
6.70%
Safer dividend
JNJ
Grade A
Faster growth
JNJ
5.2%
JNJ vs PFE — FAQ
Data refreshes daily · for informational purposes only, not investment advice.